Overall, only 27 (10.3%; 95% CI 6.9% to 14.7%) tumours showed MMR deficiency by IHC with just 7 (2.7%) having loss of MLH1 (table 2). The gene discussed is MLH1; the disease is hyperinsulinemic hypoglycemia, familial, 4.